Tirzepatide exerts its therapeutic effects through dual agonism of two key incretin receptors: the GIPR and the GLP-1R
Market Outlook and Strategic Insights The obesity and weight loss treatment landscape will undergo substantial transformation in the coming years
Constipation can happen during GLP-1 therapy because appetite, fluid intake, fiber intake, movement, and digestion may all change
Monitor Progress: Track your health care analytics, such as blood glucose levels, weight, and overall well-being regularly
BRAT foods tend to be easier
Youre seeing progress toward your health goalswhether thats steadier blood sugar, improved symptoms, or other changes that matter to you